- Public Comps
- Rubicon Organics
Rubicon Organics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Rubicon Organics and similar public comparables like iAnthus Capital Holdings, MariMed, Mountain Valley MD Hldgs, ZYUS Life Sciences and more.
Rubicon Organics Overview
About Rubicon Organics
Rubicon Organics Inc is engaged in the business of the production and sale of cannabis in Canada. The Company produces and processes organic cannabis at its wholly-owned, federally licensed facility in Delta, British Columbia which it sells under its wholly owned and other licensed brands such as Lab Theory, Wildflower, Homestead Cannabis Supply, 1964 Supply Co, and Simply Bare Organic.
Founded
2015
HQ

Employees
210
Website
Financials (LTM)
EV
$30M
Valuation Multiples
Start free trialRubicon Organics Financials
Rubicon Organics reported last 12-month revenue of $49M and EBITDA of $4M.
In the same LTM period, Rubicon Organics generated $15M in gross profit, $4M in EBITDA, and $482K in net income.
Rubicon Organics P&L
In the most recent fiscal year, Rubicon Organics reported revenue of $43M and EBITDA of $4M.
Rubicon Organics is profitable as of last fiscal year, with gross margin of 37%, EBITDA margin of 9%, and net margin of 2%.
Financial data powered by Morningstar, Inc.
Rubicon Organics Stock Performance
Rubicon Organics has current market cap of $22M, and enterprise value of $30M.
Rubicon Organics' stock price is $0.33.
Rubicon Organics has an EPS (earnings per share) of $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $30M | $22M | -8.1% | - | - | - | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRubicon Organics Valuation Multiples
Rubicon Organics trades at 0.6x EV/Revenue multiple, and 7.5x EV/EBITDA.
Rubicon Organics Financial Valuation Multiples
As of August 14, 2026, Rubicon Organics has market cap of $22M and EV of $30M.
Rubicon Organics has a P/E ratio of 46.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Rubicon Organics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Rubicon Organics Margins & Growth Rates
Rubicon Organics grew revenue by 23% and EBITDA by 13% in the last fiscal year.
In the most recent fiscal year, Rubicon Organics reported gross margin of 37%, EBITDA margin of 9%, and net margin of 2%.
Rubicon Organics Margins
Rubicon Organics Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Rubicon Organics Operational KPIs
Rubicon Organics' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Rubicon Organics' Rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Rubicon Organics' Rule of X is 65% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Rubicon Organics Competitors
Rubicon Organics competitors include iAnthus Capital Holdings, MariMed, Mountain Valley MD Hldgs, ZYUS Life Sciences, Peak Processing, Avicanna, Vitura Health, HYTN Innovations, Humanoid Global Holdings and PharmaCielo.
Most Rubicon Organics public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.7x | - | 14.0x | - | |||
| 0.7x | 0.7x | 13.4x | 6.7x | |||
| 380.5x | - | (10.9x) | - | |||
| 152.3x | - | (3.7x) | - | |||
| 1.6x | - | (8.1x) | - | |||
| 0.6x | - | (8.2x) | - | |||
| 0.2x | - | 3.2x | - | |||
| 8.9x | - | (13.0x) | - | |||
This data is available for Pro users. Sign up to see all Rubicon Organics competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Rubicon Organics
| When was Rubicon Organics founded? | Rubicon Organics was founded in 2015. |
| Where is Rubicon Organics headquartered? | Rubicon Organics is headquartered in Canada. |
| How many employees does Rubicon Organics have? | As of today, Rubicon Organics has over 210 employees. |
| Is Rubicon Organics publicly listed? | Yes, Rubicon Organics is a public company listed on Toronto Stock Exchange. |
| What is the stock symbol of Rubicon Organics? | Rubicon Organics trades under ROMJ ticker. |
| When did Rubicon Organics go public? | Rubicon Organics went public in 2018. |
| Who are competitors of Rubicon Organics? | Rubicon Organics main competitors include iAnthus Capital Holdings, MariMed, Mountain Valley MD Hldgs, ZYUS Life Sciences, Peak Processing, Avicanna, Vitura Health, HYTN Innovations, Humanoid Global Holdings, PharmaCielo. |
| What is the current market cap of Rubicon Organics? | Rubicon Organics' current market cap is $22M. |
| What is the current revenue of Rubicon Organics? | Rubicon Organics' last 12 months revenue is $49M. |
| What is the current revenue growth of Rubicon Organics? | Rubicon Organics revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Rubicon Organics? | Current revenue multiple of Rubicon Organics is 0.6x. |
| What is the current EBITDA of Rubicon Organics? | Rubicon Organics' last 12 months EBITDA is $4M. |
| What is Rubicon Organics' EBITDA margin? | Rubicon Organics' last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Rubicon Organics? | Current EBITDA multiple of Rubicon Organics is 7.5x. |
| What is the current FCF of Rubicon Organics? | Rubicon Organics' last 12 months FCF is ($4M). |
| What is Rubicon Organics' FCF margin? | Rubicon Organics' last 12 months FCF margin is (9%). |
| What is the current EV/FCF multiple of Rubicon Organics? | Current FCF multiple of Rubicon Organics is (6.8x). |
| How many companies Rubicon Organics has acquired to date? | Rubicon Organics hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Rubicon Organics has invested to date? | Rubicon Organics hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Rubicon Organics
Lists including Rubicon Organics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




